Cost Minimization Analysis (CMA) of XELOX versus MFOLFOX6 in the treatment of colorectal cancer in an universitary hospital in Brazil
Introduction: Cancer worldwide is a public health problem with a perspective of 20 million new cases by 2025. Colorectal cancer (CRC) is ranked the third most incident tumor in the world and the fourth in Brazil. Objectives: The purpose of this paper was to evaluate the effectiveness and to conduct...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia,
2023-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|